BD PharmingenTM PE Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor

Description

Two-color analysis of the expression of Vbeta 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with PE Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor Cat. No. 553190 , FITC Rat Anti-Mouse CD4 Cat. No. 553046/553047 , and FITC Rat Anti-Mouse CD8a Cat. No. 553030/553031 monoclonal antibodies. The fluorescence contour plot was derived from gated events based on the forward and side light-scattering of viable lymphocytes. Flow cytometry was performed on a BD FACScan. Two-color analysis of the expression of Vbeta 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with PE Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor Cat. No. 553190 , FITC Rat Anti-Mouse CD4 Cat. No. 553046/553047 , and FITC Rat Anti-Mouse CD8a Cat. No. 553030/553031 monoclonal antibodies. The fluorescence contour plot was derived from gated events based on the forward and side light-scattering of viable lymphocytes. Flow cytometry was performed on a BD FACScan. Show More Two-color analysis of the expression of Vbeta 5.1, 5.2 TCR on peripheral T lymphocytes. C57BL/6 lymph node cells were incubated simultaneously with PE Mouse Anti-Mouse Vbeta 5.1, 5.2 T-Cell Receptor Cat. No. 553190 , FITC Rat Anti-Mouse CD4 Cat. No. 553046/553047 , and FITC Rat Anti-Mouse CD8a Cat. No. 553030/553031 monoclonal antibodies. The fluorescence contour plot was derived from gated events based on the forward and side light-scattering of viable lymphocytes. Flow cytometry was performed on a BD FACScan.